Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

December 30, 2021
On location

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
November 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals